RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

Estimated Value: $300,000,000
Open 26 days left Washington DCHealthcaresolicitation
Jul 2, 2026
Jul 30, 2026 9:00 PM
Healthcare
solicitation
541714
AI Summary
This bid is for the late-stage clinical development, regulatory approval, and subsequent procurement of 2-PAM autoinjectors, a drug/device combination product, for treating organophosphate poisoning in both adult and pediatric populations under Project Bioshield.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Late-stage clinical development of 2-PAM autoinjectors (adult and pediatric populations) 1 project $100,000,000.00 $100,000,000.00 Professional Services
Regulatory approval (FDA) for 2-PAM autoinjectors (adult and pediatric populations) 1 project $50,000,000.00 $50,000,000.00 Professional Services
Procurement of 2-PAM autoinjectors (drug/device combination product) 1 lot $150,000,000.00 $150,000,000.00 Medical
Estimated Bid Value$300,000,000.00

Want the full details?

Sign up free to see the agency name, 2 documents, contact info, and the original bid posting link.

📎 75A50126R00002_Amendment_0001.pdf View
📎 06_RFP_PBS_2PAM_2026_Final.pdf View
Sign Up Free →

Related Bids

Browse More Bids

Bids in Washington DCHealthcare BidsSOLICITATION BidsClosing Soon All Bids